Advertisement

Topics

Roche Acquiring Flatiron Health For $1.9B To Accelerate Cancer Med Development

09:10 EST 16 Feb 2018 | Pharmaceutical Processing

News
Related Biotechnology, Pharmaceutical and Healthcare News
The companies will leverage their combined experience to advance the use of real-world evidence to set standards for oncology research and development. Flatiron Health will continue its operations as a separate legal entity.
Contributed Author: 
Roche Holding AG
Topics: 
Big Pharma

Original Article: Roche Acquiring Flatiron Health For $1.9B To Accelerate Cancer Med Development

NEXT ARTICLE

More From BioPortfolio on "Roche Acquiring Flatiron Health For $1.9B To Accelerate Cancer Med Development"

Advertisement

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
Advertisement

 

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio.
All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd.